Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 20:97:e202302013.

[Bacterial resistance, a current crisis]

[Article in Spanish]
Affiliations

[Bacterial resistance, a current crisis]

[Article in Spanish]
Luis Arturo Camacho Silvas. Rev Esp Salud Publica. .

Abstract

Bacterial resistance is a constant battle representing a Public Health trouble. So much, that the World Health Organization considerate Public Health as a priority in health, due to the impact that generates as much as in health (giving that recent projections indicate that by 2050 it'll be produced more deaths because of this than the ones occasioned because of cancer) as its economic impact (which, according to a recent study in the United Kingdom, it'll cost the world's economy an estimated of 100 trillion dollars). The quick appearance of multidrug-resistant and pandrug-resistant bacteria is a world nature phenomenon, questioning the antibiotics efficiency. Implement protocols and recommendations is essential, just as essential and necessary as give awareness to health personnel, taking as base the knowledge of resistance generation and its impact through the years, empowered by the actual pandemic of COVID 19.

La resistencia bacteriana es una constante batalla que representa un problema de Salud Pública. Tan es así que la Organización Mundial de la Salud (OMS) la considera de sus prioridades en salud, debido al impacto que genera tanto en la salud (dado que proyecciones recientes indican que para 2050 se producirán más muertes por esta causa que las ocasionadas actualmente por el cáncer), como a su impacto económico (que, de acuerdo a un estudio reciente en el Reino Unido, costará a la economía mundial un estimado de 100 billones de dólares anualmente). La veloz aparición de bacterias multirresistentes y panresistentes es un fenómeno de índole mundial, cuestionando la eficacia antibiótica. Implementar protocolos y recomendaciones es vital, de igual forma que es necesario conciencias al personal sanitario, tomando como base el conocimiento de generación de resistencia y su impacto a través de los años, potenciado por la actual pandemia de la COVID-19.

Keywords: Anti-bacterial agents; COVID-19; Drug resistance; Drug resistance bacterial; Multidrug resistance; Spain.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figura 1
Figura 1. Clasificación de los antibacterianos según sus lugares de acción.
Figura 2
Figura 2. Línea de tiempo del descubrimiento de los antibióticos y la aparición de la resistencia bacteriana.
Figura 3
Figura 3. Resistencia a los antibióticos por diseminación de genes de resistencia.
Figura 4
Figura 4. Mecanismos de resistencia a los agentes antimicrobianos.

Similar articles

Cited by

References

    1. Abushaheen MA, Muzaheed M, Fatani AJ, Alosaimi M, Mansy W, George M et al. Antimicrobial resistance, mechanisms and its clinical significance. Disease-a-Month. 2020 Jun 1;66(6). - PubMed
    2. Abushaheen MA, Muzaheed M, Fatani AJ, Alosaimi M, Mansy W, George M. Antimicrobial resistance, mechanisms and its clinical significance. Disease-a-Month. 2020 Jun 01;66(6) - PubMed
    1. I-Mohr K. History of Antibiotics Research. Curr Top Microbiol Immunol. 2016;37(October):435. - PubMed
    2. I-Mohr K. History of Antibiotics Research. Curr Top Microbiol Immunol. 2016;37:435–435. - PubMed
    1. Al-Tawfiq JA, Momattin H, Al-Ali AY, Eljaaly K, Tirupathi R, Haradwala MB et al. Antibiotics in the pipeline: a literature review (2017-2020). Vol. 50, Infection. Springer Science and Business Media Deutschland GmbH; 2022. p. 553-564. - PMC - PubMed
    2. Al-Tawfiq JA, Momattin H, Al-Ali AY, Eljaaly K, Tirupathi R, Haradwala MB. Antibiotics in the pipeline: a literature review (2017-2020) Infection. 2022;(50):553–564. - PMC - PubMed
    1. Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013;4(MAR):1-13. - PMC - PubMed
    2. Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013;(4(MAR)):1–13. - PMC - PubMed
    1. Vanegas-Múnera JM, Jiménez-Quiceno JN. Resistencia antimicrobiana en el siglo XXI: ¿hacia una era postantibiótica? Rev Fac Nac Salud Pública. Vol 38. No 1. 2020;1-6.
    2. Vanegas-Múnera JM, Jiménez-Quiceno JN. Resistencia antimicrobiana en el siglo XXI: ¿hacia una era postantibiótica? Rev Fac Nac Salud Pública. 2020;38(1):1–6.

Publication types

Substances